RyboDyn
RyboDyn is a biotechnology company developing first-in-class immunotherapies targeting the dark genome. They utilize RyboCypher, a proprietary RNA sequencing technology, to identify and validate previously unknown proteins for use in novel cancer therapies. This approach offers a unique 'targets-to-assets' strategy for therapeutic development.
Buy Funded Startups lists
Funding Round: Pre-Seed
Funding Amount: $4M
Date: 09-Jan-2025
Investors: Genedant Capital, SeaX Ventures, SOSV, Swell VC
Markets: Biotechnology, Cancer Immunotherapy, Medical, Pharmaceutical, Therapeutics, Drug Discovery, HealthTech
HQ: San Diego, California, United States
Founded: 2022
Website: https://www.rybodyn.com
LinkedIn: https://www.linkedin.com/company/rybodyn
Crunchbase: https://www.crunchbase.com/organization/rybodyn
Leave a Comment
Comments
No comments yet.